Last reviewed · How we verify
Synthetic Vitamin B1 — Competitive Intelligence Brief
marketed
Vitamin B1 (thiamine) supplement
Thiamine pyrophosphokinase (enzyme target for activation); functions as cofactor for multiple metabolic enzymes
Nutritional/Metabolic; Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Synthetic Vitamin B1 (Synthetic Vitamin B1) — ClinAmygate. Synthetic Vitamin B1 (thiamine) acts as a coenzyme in carbohydrate metabolism and nervous system function.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Synthetic Vitamin B1 TARGET | Synthetic Vitamin B1 | ClinAmygate | marketed | Vitamin B1 (thiamine) supplement | Thiamine pyrophosphokinase (enzyme target for activation); functions as cofactor for multiple metabolic enzymes |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin B1 (thiamine) supplement class)
- ClinAmygate · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Synthetic Vitamin B1 CI watch — RSS
- Synthetic Vitamin B1 CI watch — Atom
- Synthetic Vitamin B1 CI watch — JSON
- Synthetic Vitamin B1 alone — RSS
- Whole Vitamin B1 (thiamine) supplement class — RSS
Cite this brief
Drug Landscape (2026). Synthetic Vitamin B1 — Competitive Intelligence Brief. https://druglandscape.com/ci/synthetic-vitamin-b1. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab